Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Bordeaux

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Advances in Cancer Research|October 27, 2009
The function, proteolytic processing, and histopathology of Met in cancerJason A Hanna, Jennifer Bordeaux, David L Rimm, et al.
The American Journal of Pathology|March 16, 2010
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosisVeronique Neumeister, Seema Agarwal, Jennifer Bordeaux, et al.
Plos One|November 27, 2013
Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment methodYalai Bai, Huan Cheng, Jennifer Bordeaux, et al.
Biotechniques|April 3, 2010
Antibody validationJennifer Bordeaux, Allison Welsh, Seema Agarwal, et al.
Oncotarget|July 2, 2014
Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteinsDaniel J O'Shannessy, Elizabeth B Somers, Lakshmi K Chandrasekaran, et al.
Virology|December 14, 2011
The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic trafficShahan Mamoor, Zeynep Onder, Balasubramanyam Karanam, et al.
Journal for Immunotherapy of Cancer|January 21, 2017
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinomaKathryn E Beckermann, Pradeep C Jolly, Ju Y Kim, et al.
Cell Cycle (Georgetown, Tex.)|June 21, 2012
Lin28 regulates HER2 and promotes malignancy through multiple mechanismsChen Feng, Veronique Neumeister, Wei Ma, et al.
Plos One|June 27, 2014
In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patientsMaria Vassilakopoulou, Taiwo Togun, Urania Dafni, et al.
Oncoimmunology|May 17, 2017
Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profilingPeter J Siska, Romany A N Johnpulle, Alice Zhou, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Advances in Cancer Research|October 27, 2009
The function, proteolytic processing, and histopathology of Met in cancerJason A Hanna, Jennifer Bordeaux, David L Rimm, et al.
The American Journal of Pathology|March 16, 2010
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosisVeronique Neumeister, Seema Agarwal, Jennifer Bordeaux, et al.
Plos One|November 27, 2013
Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment methodYalai Bai, Huan Cheng, Jennifer Bordeaux, et al.
Biotechniques|April 3, 2010
Antibody validationJennifer Bordeaux, Allison Welsh, Seema Agarwal, et al.
Oncotarget|July 2, 2014
Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteinsDaniel J O'Shannessy, Elizabeth B Somers, Lakshmi K Chandrasekaran, et al.
Virology|December 14, 2011
The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic trafficShahan Mamoor, Zeynep Onder, Balasubramanyam Karanam, et al.
Journal for Immunotherapy of Cancer|January 21, 2017
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinomaKathryn E Beckermann, Pradeep C Jolly, Ju Y Kim, et al.
Cell Cycle (Georgetown, Tex.)|June 21, 2012
Lin28 regulates HER2 and promotes malignancy through multiple mechanismsChen Feng, Veronique Neumeister, Wei Ma, et al.
Plos One|June 27, 2014
In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patientsMaria Vassilakopoulou, Taiwo Togun, Urania Dafni, et al.
Oncoimmunology|May 17, 2017
Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profilingPeter J Siska, Romany A N Johnpulle, Alice Zhou, et al.
Pageof 2